Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

En prognostisk transkriptomisk signatur for kronisk hypersensitivitetspneumonitis (PREDICT-HP)

9. november 2026 opdateret af: Evans Fernandez Perez, National Jewish Health

Udvikling og validering af en prognostisk transkriptomisk signatur for kronisk hypersensitivitetspneumonitis

Up to 150 patients with hypersensitivity pneumonitis will be enrolled at 7 clinical centers across the United States. Patients will be followed for 24 months to determine if biomarkers in the blood can predict disease progression.

Studieoversigt

Status

Afsluttet

Betingelser

Detaljeret beskrivelse

Hypersensitivity pneumonitis is an immunologically mediated form of lung disease, resulting from inhalation exposure to a large variety of antigens. For unknown reasons, a subgroup of patients with HP without a known inciting antigen exposure develops chronic disease with progressive pulmonary fibrosis (the leading cause of death). Accurately identifying patients at risk of disease progression is necessary for prognosis and therapy.

Enrolled subjects will be followed for 24 months and complete 5 visits to one of the study centers. Blood biomarkers will be collected in addition to other clinical data to determine if these biomarkers can predict disease progression.

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

137

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Arizona
      • Tucson, Arizona, Forenede Stater, 85719
        • University of Arizona
    • California
      • Sacramento, California, Forenede Stater, 95817
        • University of California Davis
    • Colorado
      • Denver, Colorado, Forenede Stater, 80206
        • National Jewish Health
    • Illinois
      • Chicago, Illinois, Forenede Stater, 60637
        • University of Chicago
    • Minnesota
      • Rochester, Minnesota, Forenede Stater, 55905
        • Mayo Clinic
    • Texas
      • Dallas, Texas, Forenede Stater, 75390
        • University of Texas Southwestern
    • Utah
      • Salt Lake City, Utah, Forenede Stater, 84108
        • University of Utah

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 85 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

The study population consists of men and women aged 18 to 85 years old with a diagnosis of chronic hypersensitivity pneumonitis.

Beskrivelse

Inclusion Criteria:

  • Diagnosis of chronic hypersensitivity pneumonitis
  • Age 18 through 85 years.
  • Diagnosis of chronic hypersensitivity pneumonitis by HRCT
  • Able to understand and sign a written informed consent form.
  • Able to understand the importance of adherence to the study protocol and willing to follow all study requirements

Exclusion Criteria:

  • Not a suitable candidate for enrollment or unlikely to comply with the requirements of this study
  • Known explanation for the interstitial lung disease
  • Clinical diagnosis of any connective tissue disease
  • Listed or expected to receive a lung transplant within 4 months from enrollment
  • Pregnant women

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: CASE_ONLY
  • Tidsperspektiver: PROSPECTIVE

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Tid til absolut FVC (forventet procent) fald ≥10 procent
Tidsramme: Op til 24 måneder
Op til 24 måneder
Tid til absolut DLCO (forventet procent) fald ≥10 procent
Tidsramme: Op til 24 måneder
Op til 24 måneder
Tid til relativ FVC (forventet procent) fald ≥10 procent
Tidsramme: Op til 24 måneder
Op til 24 måneder
Tid til relativ DLCO (forventet procent) fald ≥10 procent
Tidsramme: Op til 24 måneder
Op til 24 måneder
Tid til relativ DLCO (forventet procent) fald ≥15 procent
Tidsramme: Op til 24 måneder
Op til 24 måneder
Tid til første dømt akut kronisk overfølsomhed pneumonitis eksacerbation
Tidsramme: Op til 24 måneder
Op til 24 måneder
Behov for en ny behandling med orale eller intravenøse steroider
Tidsramme: Op til 24 måneder
Op til 24 måneder
Tid til død af enhver årsag
Tidsramme: Op til 24 måneder
Op til 24 måneder
Ændring fra baseline i dyspnø ved brug af St. George's Respiratory Questionnaire aktivitetsscore ved måned 12
Tidsramme: 12 måneder
12 måneder
Skift fra baseline i 6-minutters gåafstand ved 6. måned
Tidsramme: 6 måneder
6 måneder
Skift fra baseline i 6-minutters gåafstand ved måned 12
Tidsramme: 12 måneder
12 måneder
Skift fra baseline i 6-minutters gåafstand ved måned 18
Tidsramme: 18 måneder
18 måneder
Skift fra baseline i 6-minutters gåafstand ved måned 24
Tidsramme: 24 måneder
24 måneder
Rate af fald i FVC (forventet procent) over 24 måneder
Tidsramme: Op til 24 måneder
Op til 24 måneder
Rate af fald i FVC (ml) over 24 måneder
Tidsramme: Op til 24 måneder
Op til 24 måneder
Fald i DLCO (forudsagt procent) over 24 måneder
Tidsramme: Op til 24 måneder
Op til 24 måneder
Rate af fald i DLCO (mmol/min/kpa) over 24 måneder
Tidsramme: Op til 24 måneder
Op til 24 måneder
Change from baseline in St. George's Respiratory Questionnaire total score at month 6
Tidsramme: 6 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

6 months
Change from baseline in St. George's Respiratory Questionnaire total score at month 12
Tidsramme: 12 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

12 months
Change from baseline in St. George's Respiratory Questionnaire total score at month 18
Tidsramme: 18 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

18 months
Change from baseline in St. George's Respiratory Questionnaire total score at month 24
Tidsramme: 24 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

24 months
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 6
Tidsramme: 6 months

Scores range from 0 to 120, with higher scores indicating greater breathlessness.

6 months
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 12
Tidsramme: 12 months

Scores range from 0 to 120, with higher scores indicating greater breathlessness.

12 months
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 18
Tidsramme: 18 months

Scores range from 0 to 120, with higher scores indicating greater breathlessness.

18 months
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 24
Tidsramme: 24 months

Scores range from 0 to 120, with higher scores indicating greater breathlessness.

24 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 6
Tidsramme: 6 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

6 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 12
Tidsramme: 12 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

12 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 18
Tidsramme: 18 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

18 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 24
Tidsramme: 24 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

24 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire activity score at month 6
Tidsramme: 6 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

6 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire activity score at month 18
Tidsramme: 18 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

18 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire activity score at month 24
Tidsramme: 24 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

24 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 6
Tidsramme: 6 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

6 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 12
Tidsramme: 12 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

12 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 18
Tidsramme: 18 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

18 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 24
Tidsramme: 24 months

The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life.

24 months
Change from baseline in CT visual (≥10 percent) score at month 12
Tidsramme: 12 months

Visual scores range from 0 to 100, with higher scores indicating more lung fibrosis.

12 months
Change from baseline in CT visual (≥10 percent) score at month 24
Tidsramme: 24 months

Visual scores range from 0 to 100, with higher scores indicating more lung fibrosis.

24 months
Change from baseline in CT quantitative (≥3.4) score at month 12
Tidsramme: 12 months

CT quantitative scores range from 0 to no upper limits, with higher scores indicating more lung fibrosis.

12 months
Change from baseline in CT quantitative (≥3.4) score at month 24
Tidsramme: 24 months

CT quantitative scores range from 0 to no upper limits, with higher scores indicating more lung fibrosis.

24 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Samarbejdspartnere

Efterforskere

  • Ledende efterforsker: Evans Fernández, MD, MS, National Jewish Health

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

6. januar 2021

Primær færdiggørelse (Faktiske)

30. juli 2026

Studieafslutning (Faktiske)

31. juli 2026

Datoer for studieregistrering

Først indsendt

30. marts 2021

Først indsendt, der opfyldte QC-kriterier

9. april 2021

Først opslået (Faktiske)

14. april 2021

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

13. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

9. november 2026

Sidst verificeret

1. april 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • R01HL148437 (U.S. NIH-bevilling/kontrakt)

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .